A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain

PHASE2TerminatedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Neuralgia
Interventions
DRUG

GRT6010

Oral solution given once daily.

DRUG

Pregabalin

Over-encapsulated pregabalin capsules 75mg twice daily on Days 1 to 3, and 150mg twice daily on Days 4 to 7.

DRUG

Matching Placebo

"Matching Placebo capsules to the over-encapsulated Pregabalin capsules and Matching Placebo oral solution to the GRT6010 solution.~Capsules twice daily on Days 1 to 7. Solution once daily."

Trial Locations (12)

D-55131

DEU001, Mainz

D-93053

DEU002, Regensburg

H-2500

HUN004, Esztergom

H-9024

HUN003, Győr

H-3526

HUN001, Miskolc

H-3800

HUN008, Szikszó

80-214

POL002, Gdansk

20-718

POL004, Lublin

02-106

POL005, Warsaw

BT2 7BA

GBR003, Belfast

G11 6NT

GBR001, Glasgow

M32 0UT

GBR002, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Grünenthal GmbH

INDUSTRY